Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is being done to learn more about a new medicine called PF-08634404 and how well it works when given with chemotherapy to people with gastroesophageal cancer that is locally advanced (spread to nearby tissues) or has spread to other parts of the body. To join the study, participants must meet the following conditions: Be 18 years or older. Have locally advanced or metastatic gastric, gastroesophageal junction or esophageal adenocarcinoma Be treatment naïve for advanced or metastatic disease Be in good physical condition and have healthy organs based on medical tests. The study has two parts: * In the first part, researchers will check how safe the study medicine in combination with chemotherapy is and how well people respond to it. * In the second part, they will compare study medicine plus chemotherapy to another approved treatment (nivolumab plus chemotherapy) to see which works better. The treatment will be given in repeated time periods called cycles.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Potwierdzony rak żołądka, połączenia żołądka z przełykiem lub przełyku, który rozprzestrzenił się lokalnie lub do innych organów
- •Dotychczas nie leczony lekami ogólnoustrojowymi z powodu zaawansowanego raka
- •Dobry stan ogólny i prawidłowo działające organy wewnętrzne
- •Prawidłowa funkcja wątroby i nerek
- •Ujemny wynik testu HER-2
- •Dodatni wynik testu PD-L1
✗ Disqualifies
- •Przerzuty do mózgu, opon mózgowych lub rdzenia kręgowego
- •Wysoki риск krwawienia lub przetoki
- •Duża operacja lub poważny uraz w ciągu ostatnich 4 tygodni przed rozpoczęciem badania
- •Historia przeszczepienia narządu lub szpiku kostnego
- •Poważne krwawienie w ciągu ostatnich 28 dni lub historia znaczących krwawień
- •Poważne choroby serca w ciągu ostatnich 6 miesięcy
- •Aktywne choroby autoimmunologiczne wymagające leczenia w ciągu ostatnich 2 lat
- •Choroba śródmiąższowa płuc związana z lekami
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 24, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (69)
Rocky Mountain Cancer Centers, LLP
Aurora, United States
Rocky Mountain Cancer Centers, LLP
Boulder, United States
Rocky Mountain Cancer Centers, LLP
Centennial, United States
Rocky Mountain Cancer Centers, LLP
Colorado Springs, United States
Rocky Mountain Cancer Centers, LLP
Colorado Springs, United States
Rocky Mountain Cancer Centers, LLP
Denver, United States
Rocky Mountain Cancer Centers, LLP
Denver, United States
Rocky Mountain Cancer Centers, LLP
Englewood, United States
Rocky Mountain Cancer Centers, LLP
Lakewood, United States
Rocky Mountain Cancer Centers, LLP
Littleton, United States
Rocky Mountain Cancer Centers, LLP
Lone Tree, United States
Rocky Mountain Cancer Centers, LLP
Longmont, United States
Rocky Mountain Cancer Centers, LLP
Pueblo, United States
Rocky Mountain Cancer Centers, LLP
Thornton, United States
Illinois Cancer Specialists
Arlington Heights, United States
Illinois CancerCare - Bloomington
Bloomington, United States
Illinois Cancer Specialists
Chicago, United States
Illinois CancerCare - Galesburg
Galesburg, United States
Illinois Cancer Specialists
Niles, United States
Illinois CancerCare-Ottawa-Fox River Cancer Center
Ottawa, United States
Illinois CancerCare-Pekin
Pekin, United States
Illinois CancerCare, P.C.
Peoria, United States
Illinois CancerCare-Peru - Valley Regional Cancer Center
Peru, United States
Illinois CancerCare-Washington
Washington, United States
Maryland Oncology Hematology, P.A.
Annapolis, United States
Maryland Oncology Hematology, P.A.
Bethesda, United States
Maryland Oncology Hematology, P.A.
Brandywine, United States
Maryland Oncology Hematology, P.A.
Columbia, United States
Maryland Oncology Hematology, P.A.
Germantown, United States
Maryland Oncology Hematology, P.A.
Largo, United States
Maryland Oncology Hematology, P.A.
Rockville, United States
Maryland Oncology Hematology, P.A.
Silver Spring, United States
Renown Health Medical Oncology
Reno, United States
Renown Office of Clinical Research
Reno, United States
Renown Regional Medical Center
Reno, United States
Atlantic Health System
Morristown, United States
Atlantic Health System / Overlook Medical Center
Summit, United States
Oncology Hematology Care Clinical Trials, LLC
Cincinnati, United States
Oncology Hematology Care Clinical Trials, LLC
Cincinnati, United States
Oncology Hematology Care Clinical Trials, LLC
Cincinnati, United States
Oncology Hematology Care Clinical Trials, LLC
Fairfield, United States
Alliance Cancer Specialists, PC
Bensalem, United States
Alliance Cancer Specialists, PC
Doylestown, United States
Alliance Cancer Specialists, PC
Horsham, United States
Alliance Cancer Specialists, PC
Langhorne, United States
Alliance Cancer Specialists, PC
Media, United States
Alliance Cancer Specialists, PC
Sellersville, United States
Alliance Cancer Specialists, PC
Wynnewood, United States
US Oncology Investigational Products Center (IPC)
Irving, United States
Virginia Cancer Specialists, PC
Arlington, United States
Virginia Oncology Associates
Chesapeake, United States
Virginia Cancer Specialists, PC
Fairfax, United States
Virginia Oncology Associates
Hampton, United States
Virginia Cancer Specialists, PC
Manassas, United States
Virginia Oncology Associates
Newport News, United States
Virginia Oncology Associates
Norfolk, United States
Virginia Cancer Specialists, PC
Reston, United States
Virginia Oncology Associates
Virginia Beach, United States
Virginia Cancer Specialists, PC
Woodbridge, United States
Zhongshan Hospital,Fudan University
Shanghai, China
Rabin Medical Center
Petah Tikva, Israel
Sheba Medical Center
Ramat Gan, Israel
Sourasky Medical Center
Tel Aviv, Israel
Aichi Cancer Center
Nagoya, Japan
Pan American Center for Oncology Trials, LLC - Manati Office
Manati, Puerto Rico
Pan American Center for Oncology Trials, LLC - Bayamón Office
Bayamón, Puerto Rico
National Cheng Kung University Hospital
Tainan, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Trial contact
Pfizer CT.gov Call Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/26/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.